Managing the Defeated Dermatome: Clinical Dilemmas, Decision-Making, and Technical Execution of Repeat Subarachnoid Blocks
DOI:
https://doi.org/10.47363/JSAR/2026(7)271Keywords:
Spinal Anaesthesia, Repeat Spinal, Failed Spinal, Subarachnoid BlockAbstract
Background: Subarachnoid block (SAB), or spinal anaesthesia, is a cornerstone of modern regional anaesthesia, highly valued for its rapid onset, profound blockade, and minimal systemic drug burden across various surgical specialties. Despite its perceived simplicity, an unexpected block failure rapidly transitions a routine workflow into a high-stress scenario, imposing significant physical and psychological burdens on patients while increasing medicolegal vulnerability for the surgical team.
Objective: This article provides a comprehensive evaluation of managing failed subarachnoid blocks, detailing the underlying mechanisms of failure, clinical decision-making timelines, safe rescue execution techniques, dosage adjustments, and associated complications.
Discussion: When faced with an inadequate or absent block, anaesthesiologists must navigate limited rescue pathways, including local infiltration, systemic sedation, conversion to general anaesthesia (GA), or executing a repeat subarachnoid block. While GA serves as a reliable safety net, it introduces distinct risks-particularly in obstetric populations, such as difficult airways and gastric aspiration. Consequently, repeating the SAB emerges as a highly effective alternative. However, to safely manage and execute a repeat block, clinicians must accurately deduce the root cause of the initial failure. Spinal anaesthesia failure is a complex interplay of anatomy, physics, and pharmacology that can be categorized into three distinct clinical phases: failure to access the subarachnoid space, failure of local aesthetic distribution within the cerebrospinal fluid (CSF), and failure of drug action at the neural membranes.
Conclusion: Successfully managing a failed SAB relies on accurate phase-based troubleshooting and a precise understanding of the altered pharmacodynamic landscape before attempting a second intrathecal injection.